Hematologic Oncology Cancer Types and Programs

The Center for Hematologic Oncology provides specialized care for all types of cancers of the blood, including leukemia, lymphoma, multiple myeloma, histiocytosis, and Waldenström's macroglobulinemia, as well as related disorders of the blood, such as aplastic anemia and myelodysplasia.

The center also includes the bone marrow/stem cell transplantation program, which is one of the largest and most experienced in the world.

We develop personalized, comprehensive treatment plans for all our patients, offering the latest therapies and supportive resources, and taking your particular needs into account.

New Patient Appointments
877-442-3324
Make Appointment Online

Our specialized centers and programs
Lymphoma Program
The Lymphoma Program provides care for the many varieties of lymphoid malignancies, including Non-Hodgkin lymphoma (NHL), Hodgkin lymphoma, B-cell neoplasms, and T-cell neoplasms.

Hodgkin Lymphoma

Non-Hodgkin Lymphoma

Center for Chronic Lymphocytic Leukemia (CLL)
The Chronic Lymphocytic Leukemia Program provides care for patients with chronic lymphocytic leukemia (CLL), and offers access to clinical trials of promising new therapies.

Chronic Lymphocytic Leukemia (CLL)

Multiple Myeloma Program
The Jerome Lipper Multiple Myeloma Center and LeBow Institute for Myeloma Therapeutics provide care to patients with multiple myeloma, including promising new therapies through clinical trials.

Multiple Myeloma

Waldenström's Macroglobulinemia Program
The Bing Center for Waldenström's Macroglobulinemia provides care and new therapies through clinical trials to patients with Waldenström's macroglobulinemia and related Immunoglobulin M (IgM) disorders.

Waldenström's Macroglobulinemia

Adult Leukemia Program
The Adult Leukemia Program provides care for patients with leukemia and related bone marrow disorders, including acute myeloid leukemia (AML), acute lymphocytic leukemia (ALL), chronic myelogenous leukemia (CML), and related bone marrow disorders, such as myelodysplasia and myelofibrosis.

Acute lymphoblastic leukemia (ALL)

Acute myeloid leukemia (AML)

Chronic myelogenous leukemia (CML)

Adult Bone Marrow Failure Syndromes

Myelodysplastic Syndromes (MDS)

Myeloproliferative Neoplasms (MPNs)

Division of Stem Cell Transplantation and Cellular Therapies
Our stem cell transplantation program is one of the largest and most experienced transplant centers in the world, and our cellular therapies program is at the forefront of emerging cellular therapies that help the immune system fight cancer such as CAR T-cell therapy, cancer vaccines, NK cell therapy, and genetically-modified immune cells.

Stem Cell Transplantation Program

Cellular Therapies Program

Adult Histiocyte Disorders Center
The Adult Histiocyte Disorders Center provides highly effective, personalized treatment options for patients with adult histiocytosis and histiocyte disorders – rare diseases resulting from over-production of white blood cells (histiocytes), which can lead to tumors and organ damage.

Histiocytosis

Older Adult Hematologic Malignancy (OHM) Program
The OHM Program is a research and clinical service that addresses the specialized needs of blood cancer patients who are age 75 and older.

Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN) Center
The BPDCN Center combines world-class patient care with leading-edge research — providing highly effective, personalized treatment options for patients with blastic plasmacytoid dendritic cell neoplasm (BPDCN), a rare and aggressive hematologic malignancy. Our center is among the first in the U.S. for care and research for patients with BPDCN.
Center for Prevention of Progression
The Center for Prevention of Progression is the first-of-its-kind clinic for patients with precursor conditions of hematologic malignancies. Building on our research of precursor conditions, the clinic evaluates individuals diagnosed with these conditions or at high risk for disease development, and works with patients to manage their risk of disease progression.

Amyloidosis Program
The Amyloidosis Program is highly specialized and dedicated to the diagnosis, research, and treatment of this underappreciated and often misdiagnosed disease. Our approach to treatment is unique in that it is grounded in science and laboratory-based discovery. We provide access to clinical trials, innovative therapies, and unparalleled patient-centered care.
Hematologic malignancies we treat include:

Agnogenic myeloid metaplasia
Aids-related malignancies
Amyloidosis
Aplastic anemia and paroxysmal nocturnal hemoglobinuria (PNH)
Autoimmune disorders
BPDCN
Burkitt lymphoma
Castleman's syndrome
Chronic myeloid monocytic leukemia (CMML)
CNS primary lymphoma
Congenital disorders of blood production (sickle cell anemia, thalassemia), Blackfan-Diamond, Shwachman-Diamond, and Dyskeratosis Congenita syndromes
Eosinophilia
Essential thrombocytosis
Hairy cell leukemia
Histiocytosis
Jak 2 disease
Langerhans cell histiocytosis
Leukocytosis
Leukopenia
Lymphoproliferative disorder
Mastocytosis
Megaloblastic anemia
Monoclonal gammopathies
Monoclonal paraprotein/M-GUS
Mycosis fungoides/cut-cell lymphoma
Myelodysplastic syndromes (MDS)
Myelofibrosis
Myeloid metaplasia
Myeloproliferative Neoplasms (MPNs)
Neutropenia pancytopenia
NK cell lymphoma
Philadelphia positive disease
Polycythemia vera
Testicular cancer
Testicular choriocarcinoma
Thrombocytopenia
Thrombocytosis
Waldenström's macroglobulinemia
The Eleanor and Maxwell Blum Patient and Family Resource Center

The Blum Resource Center provides patients and family members with a comfortable environment to learn more about disease treatment and management.

Nutrition Services

Our nutrition experts help patients follow a healthy diet during and after cancer treatment.

Healthy recipes

Meal planning

Join Our Online Cancer Community

Join Dana-Farber's online cancer community and connect with other patients and survivors for support and information.

Hematologic Oncology Treatment Center

Hematologic Oncology Cancer Types and Programs

Our specialized centers and programs

Hematologic malignancies we treat include: